期刊文献+

中国HIV/AIDS典型进展者与疾病长期不进展者中和抗体保守表位氨基酸变异比较研究

Study on amino acids mutation of conserved neutralization epitopes of HIV/AIDS progressors and long-term nonprogressors in China
原文传递
导出
摘要 目的研究中国HIV/AIDS典型进展者及疾病长期不进展者(LTNP)中和抗体保守表位氨基酸变异,探讨中和抗体表位变异与疾病进展关系,为开展中和抗体免疫治疗和疫苗设计奠定理论基础。方法RT-PCR及巢式PCR扩增HIV/AIDS典型进展者及LTNP的HIV-1 gp120 C2-C3区基因,双脱氧终止法进行核酸序列测定,翻译为氨基酸序列,与HIV-1 Sequence Databme参考毒株比对识别中和抗体保守表位氨基酸变异。结果HIV/AIDS典型进展者CD4结合位点(CD4BS)、CD4诱导(CD4i)、2G12中和抗体保守表位氨基酸均存在变异,LTNP2G12中和抗体保守表位氨基酸存在变异;LTNP各表位突变率较典型进展的HIV感染者/AIDS患者有降低趋势,但差异无统计学意义(P〉0.05);CD4BS、CD4i、2G12变异表位构成比分别为25.0%、22.9%、52.1%,2G12表位变异明显高于CD4BS和CD4i表位,差异有统计学意义(P〈0.01);CD4BS和CD4i保守表位变异多见于E370Q(10.8%),2G12保守表位变异多见于N295V(18.9%)和T2971(9.5%)。结论中国HIV感染人群中,LTNP中和抗体保守表位氨基酸构成相对稳定,变异较典型进展的HIV感染者/AIDS患者少见,目前发现2G12中和抗体表位存在较低水平变异。中和抗体表位中,2G12表位变异较CD4BS和CD4i表位多见,各类型中和抗体保守表位氨基酸位点的变异程度存在差异。 Objective To study the amino acids mutation of conserved neutralization epitopes of HIV/AIDS patients and long-term nonprogressors (LTNP) in China, and to provide a basis for design of vaccine and immunotherapy with antibody. Methods RT-PCR and nest-PCR methods were used to amplify gene on HIV-1 gp120 C2-C3 region. Nucleic acids were sequenced by double-deoxygen terminal method and translated into amino acids for analysis. The mutations of conserved neutralization epitope were identified by comparison with the epitope reference data in HIV-1 Sequence Database. Results HIV/AIDS patients had conserved neutralization epitope mutation, including CD4-binding site (CD4BS), CD4-induced (CD4i) and 2G12; LTNP group had 2G12 epitope mutation. The mutation rates had no significant difference (P 〉 0.05) among HIV/AIDS patients and LTNP. The constituent ratios of mutation epitope of CD4BS, CD4i and 2G12 were 25.0%, 22.9% and 52. 1%, respectively (P 〈0. 01 ). CD4BS and CD4i conserved neutralization epitope mutation focused on E370Q ( 10.8% ), 2G12 conserved neutralization epitope mutation focused on N295V(18.9% ) and T297I (9.5%). Conclusion In China, LTNP had stable conserved neutralization epitope and rarely happened amino acids mutation except 2G12 epitope compared with HIV/AIDS patients. Among mutant neutralization epitope on HIV gp120 C2-C3 region, the constituent ratio of 2G12 epitope was much higher than that of CD4BS and CD4i epitope. The mutation degrees of amino acids on conserved neutralization epitope were different.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2008年第1期78-82,共5页 Chinese Journal of Microbiology and Immunology
基金 “十五”国家科技攻关课题资助项目(2004BA719A12) 国家自然科学基金资助项目(30471548)
关键词 人类免疫缺陷病毒 中和抗体 表位 突变 Human immunodeficiency virus Neutralizing antibody Epitope Mutation
  • 相关文献

参考文献11

  • 1王倩,尚红,张子宁,韩晓旭,姜拥军,王亚男,刁莹莹,代娣.中国HIV-1感染人群中和抗体水平与疾病进展关系研究[J].中华微生物学和免疫学杂志,2006,26(10):894-897. 被引量:2
  • 2RoUman E, Hinkula J, Arteaga J, et al. Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HlV antibodies. Gene Ther, 2004, 11(14): 1146-1154.
  • 3Maseola JR. Defining the protective antibody response for HIV-1. Curt Mol Med, 2003, 3(3): 209-216.
  • 4Agrawal L, Haq W, Hanson CV, et al. Generating neutralizing antibodies, Thl response and MHC non restricted immunogenicity of HIV- Ⅰ env and gag peptides in liposomes and ISCOMs with inbuilt adjuvanticity. J Immune Based Ther Vaccines, 2003, 1 ( 1 ) : 5.
  • 5Wei X, Decker JM, Wang S, et al. Antibody neutralization and escape by HIV-1. Nature, 2003, 422(6929) : 307-312.
  • 6Wyatt R, Kwong PD, Desjardins E, et al. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature, 1998, 393 (6686) : 705-711.
  • 7Moore JP, Sodroski J. Antibody cruss-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J Virul, 1996, 70(3) : 1863-1872.
  • 8Thali M, Furman C, Ho DD, et al. Discontinuous, conserved neutralization epitopes overlapping the CD4 binding region of the HIV-1 gp120 envelope glycoprotein. J Virol, 1992, 66 (9):5635-5641.
  • 9Ho DD, Mckeating JA, Li XL, et al. Conformational epitope on gp120 important in CD4 binding and human immuno-deficiency virus type 1 neutralization identified by a human monoclonal antibody. J Virul, 1991, 65(1) : 489-493.
  • 10Thali M, Moore JP, Furman C, et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol, 1993, 67 (7) : 3978-3988.

二级参考文献19

  • 1Buchbinder SP,Katz MH,Hessol NA,etal.Long-term HIV-1 infection without immunological progression.AIDS,1994,8(8):1123-1128.
  • 2Sheppard HW,Lang W,Ascher MS,et al.The characterization of nonprogressors:long-termHIV-1 infection with stable CD4 T-cell levels.AIDS,1993,7(9):1159-1166.
  • 3Munoz A,Kirby AJ,He YD,et al.Long-term survivors with HIV-1 infection:incubation periodand longitudinal patterns of CD4 lymphocytes.J Acquir Immune Defic Syndr HumRetrovirol,1995,8(5):496-505.
  • 4Zhang L,Huang Y,Yuan H,et al.Genetic characterization of VIF,VPR and VPU sequences fromlong-term survivors of human immunodeficiency virus type 1infection.Virol,1997,228(2):340-349.
  • 5Huang Y,Zhang L,Ho DD.Characterization of nef sequences in longterm survivors of humanimmunodeficiency virus type 1 infection.J Virol,1995,69(1):93-100.
  • 6Pantaleo G,Menzo S,Vaccarezza M,et al.Studies in subjects with long-term nonprogressivehuman immunodeficiency virus infection.N Engl J Med,1995,332(4):209-216.
  • 7Lifson AR,Buchbinder SP,Sheppard HW,et al.Long-term human immunodeficiency virusinfection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocytecounts:immunologic and virologic characteristics.J Infect Dis,1991,163(5):959-965.
  • 8Yamanaka T,Fujimura Y,Ishimoto S,et al.Correlation of titer of antibody to principalneutralizing domain of HIV (MN) strain with disease progression in Japanese hemophiliacsseropositive for HIV type 1.AIDS Res Hum Retroviruses,1997,13(4):317-326.
  • 9Karpas A,Hill F,Youle M,et al.Effects of passive immunization in patients with theacquired immunodeficiency syndrome-related complex and acquired immunodeficiencysyndrome.Proc Natl Acad Sci USA,1988,85(23):9234-9237.
  • 10Ljunggren K,Moschese V,Broliden PA,et al.Antibodies mediating cellular cytotoxicityand neutralization correlate with a better clinical staage in children born to humanimmunodeficiency virus infected mothers.J Infect Dis,1990,161(2):198-202.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部